Ophthalmologists must embrace corneal diagnostics to select the proper patient for premium multifocal IOLs, according to a ...

The rationale for the study was anecdotal reports of the effects of breast milk used by mothers to treat blocked tear ducts, ...

OSN, a roundtable discusses the management of epithelial ingrowth after LASIK, neurotrophic keratitis and Demodex blepharitis ...

IVIEW Therapeutics Inc., a clinical-stage biotechnology company dedicated to advancing innovative treatments for ocular diseases, today announced positive topline data from its Phase 1/2 clinical ...

Samples from all patients were taken and cultured. Corneal scrapings were obtained under topical anesthesia. These were smeared for potassium hydroxide (KOH) and Gram staining was performed. They were ...

The doctor will look at your eye and use a product called eye stain that lets them see the surface of your cornea. If something is on it or in it, they can safely remove it. A corneal abrasion ...

Methods 434 women and 101 men self-reported prior medical history and underwent a standardised DED assessment using the Ocular Surface Disease Index, Brief Pain Inventory, Tear Break-Up Time (TBUT)(s) ...

Using a consensus-based approach, they assessed 14 commonly used DED severity criteria. The panel agreed that following confirmed DED diagnosis, just two criteria, symptom-based assessment and corneal ...

Additionally, TFBUT, corneal fluorescein staining (CFS) for keratoconjunctival vital staining, maximum blink interval (MBI) and Schirmer test I for reflex tear production were assessed for both eyes.

The best carpet stain removers can be a lifesaver. Many of us have been there, and witnessed that moment when time slows down and a glass of red wine tumbles and splashes across your light carpet.

Neuropathic corneal pain, often resulting from conditions ... namely “total conjunctival staining” as measured by the Ora Calibra Staining Scale as early as Day 29 (p = 0.034).

OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an ...